A Conditional Answer: Why the Cognitive Case for Creatine Remains Open

The question is whether creatine monohydrate improves adult cognitive performance, and the evidence supports a more careful answer than either a supplement advertisement or a debunking headline. The proposed brain-energy mechanism is plausible. A 2024 meta-analysis reported positive results for memory and selected time-based attention and processing-speed outcomes. But the central memory estimate is challenged by a 2026 critique of how correlated outcomes were counted. The judgment this series supports is therefore conditional: some measured effects may be real, yet the current evidence does not establish creatine as a universal cognitive enhancer, a treatment, or a prevention strategy.

The evidence chain points to a conditional signal

The biological case begins with the creatine–phosphocreatine–ATP system. Creatine is taken up by cells and participates in a process in which phosphocreatine can be broken down through creatine kinase to help regenerate ATP. Because brain cells perform energy-demanding work, the 2024 review presents this system as a reason to investigate whether creatine could influence cognition. The mechanism makes the question sensible. It does not answer it.

A mechanism becomes evidence only when it is connected to a human comparison and a defined outcome. The adult trials in the review measured memory, attention, executive function, processing speed, and overall cognition through scores and completion times. That distinction determines what each result means. A memory test is not a measure of every form of learning. A faster attention task is not the same as better concentration in daily life. A processing-speed result does not automatically imply better comprehension or judgment.

The 2024 synthesis reported a positive memory effect: a standardized mean difference of 0.31, with a 95% confidence interval from 0.18 to 0.44, and a Hedges’ g of about 0.30. It also reported faster completion of attention tasks, with an SMD of −0.31, and faster processing-speed task completion, with an SMD of −0.51. In the time-based outcomes, the negative direction represents less time to complete the task. These are not trivial distinctions. They keep the numerical result attached to the behavior that was actually measured.

The same synthesis did not find statistically significant improvements in overall cognitive function, executive-function scores, executive-function time, attention scores, or processing-speed scores. That mixed pattern is evidence against a simple story in which creatine improves cognition as a whole. It is compatible with a narrower possibility: effects, if present, may depend on the task, the population, the intervention conditions, or the sensitivity of the measurement.

The review rated the memory evidence as moderate certainty and rated the evidence for processing speed, overall cognition, executive function, and attention as low to very low certainty. These judgments do not turn the positive memory result into proof, and they do not make the null domains proof of no effect. They indicate that confidence should differ by outcome. A responsible conclusion must carry the variation rather than selecting the strongest result and treating it as representative of all the others.

The causal chain can be kept in view:

flowchart LR A["Brain-energy plausibility"] --> B["Adult randomized trials"] B --> C["2024 reported memory and time signals"] C --> D{"Independent outcomes modeled?"} D --> E["Conditional evidence"] D --> F["Precision remains contested"] E --> G["Population and endpoint limits"] F --> G G --> H["Plausible, not universal enhancement"] H --> I["Corrected synthesis and stronger trials can update confidence"]